United States Anaphylaxis Market: Surged Adoption of Novel Therapeutics Such as Auto-Injectors Anchor Growth
Onward rise in incidences of anaphylactic reaction in United States triggered by host of factors such as foods and drugs often resulting in fatality has augmented advancements in anaphylaxis therapeutics in recent years. Ongoing progress in novel treatment and diagnosis services are likely to prompt growth in United States anaphylaxis market. Aforementioned market insights along with other valuable market highlights have been divulged in a new market intelligence report titled, 'United States Anaphylaxis Market by Food Sources, End Users, and...
View full press release